7.6 C
New York
Sunday, November 27, 2022
Coronavirus lockdowns have led to an unprecedented fall in air pollution for these major cities. However, there has been a silver lining too. The Earth has begun breathing again after the factories closed down. The air quality has improved in many cities. Swiss-based air quality technology company, IQAir, which measured...
The Senate is taking measures to aid in the process of re-opening the economy. A ‘Phase 3.5’ relief bill to replenish PPP (Paycheck Protection Program) which aids small businesses was passed on Tuesday. Hospitals are provided with another $75 billion to fast-track the process of widespread testing. The vote to...
As states begin preparations for the re-opening of the economy, news hits that August will see a 10% increase in the coronavirus death toll than was expected before. Death tallies drawn up recently reveal that the number of deaths will continue to grow. Amidst such a state, Health Institutes believe...
As per Matt Hancock, the Health Secretary of the UK, the coronavirus is at its peak in the UK. However, there are a couple of tests that have to be made before any thought of lifting the lockdown is implemented. He has, however, spoken against giving people free masks.  "We...
The recent autopsy report of two deceased persons from Northern California’s Santa Clara County reveals that the two had died of the coronavirus in early and mid-February, 3 weeks before the first official COVID-19 death. According to health experts, this revelation will help in studying the virus profoundly as to...
According to Germany’s Federal Institute of Vaccine, a clinical trial for Coronavirus vaccine has been approved in which healthy individuals from 18 to 35 years of age will receive several variants of the vaccine. The vaccine for the trial which has registered 200 participants was developed by German biotech company...
According to a new study published in The Lancet on Friday, not only the lungs but the blood vessel linings all over the body are also attacked by the novel coronavirus. Frank Ruschitzka from University Hospital Zurich said that it attacks the endothelium, a layer of cells that acts as...
Novartis, the Swiss multinational pharmaceutical company has been given a green light by the U.S. Food and Drug Administration (FDA) to conduct a clinical trial of hydroxychloroquine for coronavirus patients.  The pharma company announced its intentions to start phase III of its clinical trial within the next few weeks. The...